Carl Cooley, MD — Collaborative Care among Specialists, Families, and the Primary Care Medical Home for Children with Genetic Conditions (SERN/SERGG 2011)
Dr. Carl Cooley presenting on Medical Home.
Christine Eng, MD — Clinical Whole Exome Sequencing For the Evaluation of Genetic Disorders (SERN/SERGG 2013)
Dr. Eng presents on whole exome sequencing.
Clinical Application of Microarray Technology on Hematological Malignancies and Solid Tumor: The CCMC Experience
Dr. Li presents at the 2010 SERGG Annual Meeting.
Basic Building Blocks for Biomedical Ontologies
Dr. Barry Smith presents on biomedical ontology. This is the second in a two-part series.
A Miraculous New Era for Cystic Fibrosis: Impact of Molecular Screening and Therapy.
The third annual Paul M. Fernhoff Memorial Lecture was held Thursday, September 17, 2015. Dr. Philip Farrell’s keynote address is available here entitled “A Miraculous New Era for Cystic Fibrosis: … More →
Direct to Consumer Telemedicine Application
Lloyd Sirmons presents on Direct to Consumer Telemedicine Application, with focus on how the DTC market changed with the onset of COVID-19.
The Art of Choosing
Dr. Iyengar presents on the implications of choice.
Telegenetics in Region 3 (SERC): Past Successes and Plans for the Future
Dr. Andersson speaks about telegenetics activities in the Southeast Region Collaborative. This is the first of a two-part presentation along with Dr. David Flannery (presentation also available on SERC).
Meg Comeau, MHA — State Statutes and Legislation Related to Coverage of Dietary Treatments of Heritable Disorders (SERN/SERGG 2017)
Keynote Address: “State Statutes and Legislation Related to Coverage of Dietary Treatments of Heritable Disorders” Meg Comeau, MHA, Catalyst Center, Boston University School of Public Health
Michael Bober, MD, PhD — Skeletal Dysplasia: Overview and Emerging Therapies (SERN/SERGG 2013)
Dr. Bober presents on skeletal dysplasia.
Stuart Shapira, MD, PhD — Routine Second Testing in Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia: Is One Screening Test Sufficient? (SERN/SERGG 2012)
Dr. Shapira presents on Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia.
Pedro Juan Santiago Borrero, MD — Researching Genetic Diseases in Puerto Rico (SERN/SERGG 2011)
Dr. Santiago presents on genetic disease research in Puerto Rico.
Project ECHO “The democratization of medical knowledge
Dr. Hawkins presents, “Project ECHO: The democratization of medical knowledge”
Emily Lisi, MS, CGC — The Current Status of Direct-to-Consumer Genetic Testing (SERN/SERGG 2017)
Invited Speaker: Emily Lisi, MS, CGC – Mayo Clinic “The Current Status of Direct-to-Consumer Genetic Testing”
The Exciting World of Genetics in India – From Clinical to Chromosomes, and Metabolic to Molecular
Dr. Verma presents on genetics in India.
The Importance of Standardization of Language and Coding for Newborn Screening
Dr. Zuckerman presents at the 2010 SERGG Annual Meeting.
What’s New in Newborn Screening – July 2010
Dr. Therrell presents at the 2010 SERGG Annual Meeting.
Elizabeth Krupinski, PhD — Vision for Telemedicine (SERN/SERGG 2017)
“Vision for Telemedicine” Elizabeth A. Krupinski, PhD, Emory University School of Medicine
Kirk L. Pappan, PhD — Using Clinical Metabolomics to Screen for Inborn Errors of Metabolism (SERN/SERGG 2017)
Dr. Pappan presents, “Using Clinical Metabolomics to Screen for Inborn Errors of Metabolism”